Am J Otolaryngol Head Neck Surg | Volume 6, Issue 3 | Research Article | Open Access
Ribeiro FAQ1*, Mitre EI1, Dobrianskyj FM2 and Kobayashi AF2
1Department of Otorhinolaryngology, Faculty of Medical Sciences of Santa Casa de São Paulo, Brazil
2Department of Otorhinolaryngology, Irmandade da Santa Casa de Misericórdia de São Paulo, Brazil
*Correspondance to: Fernando de Andrade Quintanilha RibeiroFulltext PDF
Background: External Auditory Canal Cholesteatoma (EACC) is a disease in which the canal skin spontaneously acquires a hyperproliferative osteolytic nature leading to canal enlargement which can invade the middle ear and mastoid. The treatment of choice is generally surgical, while clinical approaches tend to be ineffective. Objective: To assess the outcomes of clinical treatment of cholesteatoma involving the external auditory canal only using clobetasol propionate. Material and Methods: Cases with spontaneous cholesteatoma of the EAC treated at the otologic surgery clinic of a university teaching hospital between 2011 and 2018 were assessed. The sample included only cases involving the EAC presenting no erosion into the mastoid cavity or tympanic membrane perforation. Results: Of the 18 cases followed, disease control was achieved in 14 (77.7%), whereas no improvement was observed in 4 cases (22.2%). Conclusion: Clinical treatment using Clobetasol Propionate controlled the disease in a large number of patients, precluding the need for traditional surgical procedures.
Cholesteatoma; External auditory canal; Surgery; Clobetasol propionate
Ribeiro FAQ, Mitre EI, Dobrianskyj FM, Kobayashi AF. Proposal for a New Clinical Treatment of Spontaneous Cholesteatoma of the External Auditory Canal with Clobetasol Propionate. Am J Otolaryngol Head Neck Surg. 2023; 6(3):1235.